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Predictors of Failure After Placement of
Charleston Area Medical Center, Charleston, WV Objectives: With current nationwide increase in the number of patients on dialysis and with guidelines of Centers for Medicare and Medicaid Services, the use of peritoneal dialysis (PD) catheter continues to increase. This study examined long-term outcomes and factors associated in PD catheter survival in patients with renal failure.
Methods: A retrospective review of patients who had PD catheter placed for dialysis after renal failure. Electronic medical records were reviewed for demographic and clinical information of the patients. The primary end point of the study was PD catheter failure, defined as removal of a dysfunctional PD catheter owing to catheter-related complications. Catheter survival was estimated using the Kaplan-Meier method, whereas Cox proportional hazard regression was used to identify factors that are independently predict PD catheter failure.
Results: Seventy-one PD catheters were placed (69 had laparoscopic and 2 had open surgery) in 55 patients (mean, 1.3 attempts). Demographics at the time of catheter placement indicated more were male (52.1%) with a mean 6 standard deviation age of 58.4 6 14.5 years and body mass index of 28.8 6 9.8 kg/m 2 . The majority were in renal failure (n ¼ 59; 83.1%); the rest had stage 5 chronic kidney disease (n ¼ 12; 16.9%). Overall patency or the average time that patients remained on PD was 3 years (median, 32.2 months; Fig) . Diabetes was associated with a higher, but not significantly, rate of catheter related peritonitis (25.6 vs 9.4%; P ¼ .123). Forty-three patients (60.6%) had previous abdominal surgery. Overall PD catheter survival rates over 12, 24, and 36 months were (percent + standard error) 86.6% + 3.7%, 69.6% + 5.7%, and 62.7% + 6.1%, respectively with nine patients remaining on catheter beyond 5 years. Previous abdominal surgery (hazard ratio [HR], 2.6; 95% confidence interval [CI], 1.2-5.6), diabetes (HR, 2.6; 95% CI, 1.2-5.6), and BMI >35 kg/m 2 (HR, 0.33; 95% CI, 0.13-0.84) were significant independent predictors of PD catheter failure. No other risk factors including age, gender or comorbidities were found to be predictors of PD catheter failure.
Conclusions: This study highlights an excellent 3-year PD catheter survival rate with patients extending beyond 5 years. Previous abdominal surgery, diabetes, and a BMI of >35 kg/m 2 were significant independent predictors of PD catheter failure. Other factors such as age, gender, and comorbidities were found not to be predictive. Interestingly, a BMI of >35 kg/m 2 was found to be protective of PD catheter failure. Objectives: Central vein stenosis and occlusion is the leading cause of fistula and graft failure in hemodialysis patients. The HeRO graft (Merit medical systems, Inc., South Jordan, Utah) is a new technique for vascular access in patients with limited treatment options. The graft, consisting of standard expanded polytetrafluroethilene graft combined with a ringsupported polyethylene outflow component, is placed subcutaneously in the upper arm providing a continuous blood flow from the brachial artery direct to the right atrium. The aim of study is to report the first results of a multicenter study on this device implantation in patients with end stages of kidney disease from three centers in Germany.
Methods: All patients with no further treatment options except catheter based dialysis and who got the HeRO device in three German hospitals were included in the study. All three hospitals are high-volume vascular access centers with common case load of more than 3000 case per year. Between the July 2013 and August 2017, a HeRO graft implantation was scheduled in 45 patients. In two patients, HeRO could not be placed for non-device-related reasons, and we, thus, retrieved data of the remaining 43 patients in whom the device was successfully implanted. In all cases, the device was implanted on the upper limb.
Results: Of the 43 patients enrolled in the study there were 18 men and 25 women. The mean age of patient was 64.3 6 16 years and 26 of the 43 had diabetes. In four cases, a Surfacer device was used for the implantation of the graft. A left-sided HeRO graft implantation performed in 21 cases and the right side was used in 22 cases. No intraoperative complications during the implantation were observed. The primary 1-year patency after implantation of HeRO graft was 39%, and the 1-year secondary patency was 94,1%. An infection after HeRO graft implantation 
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